2024
May 31, 2024
Ziphius Appoints Trudy Vanhove as Non-Executive Director and Announces New York Office Opening
May 24, 2024
Ziphius Extends Board with former VIB Managing Director Jo Bury as non-executive Director and Chairman
2023
Jan 13, 2023
Ziphius Vaccines Appoints Former Head of Janssen Vaccines R&D as Chief Scientific Advisor
2022
Oct 7, 2022
Ziphius Vaccines and UZ Ghent Establish Unique Collaboration for GMP Manufacturing of saRNA-Based Vaccines
Jun 23, 2022
Charles River and Ziphius Vaccines Collaborate to Manufacture saRNA-Based Vaccine
Jun 9, 2022
Ziphius Vaccines and University of Antwerp Announce Collaboration Agreement for Optimized Delivery of saRNA-based Vaccines & Therapeutics
May 6, 2022
Ziphius Vaccines and Ghent University Publish Promising Data from self-amplifying RNA Platform in Molecular Therapy
2021
Sep 21, 2021
Ziphius Vaccines Accelerates its Promising sa-RNA Program with Two Senior Executive Appointments